Artwork

Indhold leveret af Certara Evidence & Access and Certara Evidence. Alt podcastindhold inklusive episoder, grafik og podcastbeskrivelser uploades og leveres direkte af Certara Evidence & Access and Certara Evidence eller deres podcastplatformspartner. Hvis du mener, at nogen bruger dit ophavsretligt beskyttede værk uden din tilladelse, kan du følge processen beskrevet her https://da.player.fm/legal.
Player FM - Podcast-app
Gå offline med appen Player FM !

(1): Outcomes Based Agreements: Deal or No Deal

1:07:38
 
Del
 

Manage episode 214495668 series 2415349
Indhold leveret af Certara Evidence & Access and Certara Evidence. Alt podcastindhold inklusive episoder, grafik og podcastbeskrivelser uploades og leveres direkte af Certara Evidence & Access and Certara Evidence eller deres podcastplatformspartner. Hvis du mener, at nogen bruger dit ophavsretligt beskyttede værk uden din tilladelse, kan du følge processen beskrevet her https://da.player.fm/legal.
In our first episode, we're shining a light on the next frontier for outcomes-based agreements (OBA). If we move beyond the initial excitement and PR, where does pharma stand on risk-sharing and innovative contracting? Experts Roman Casciano, GM, Analytica Laser & SVP, Market Access, HEOR and Real-world Evidence, Certara Lee Stern, VP, Business Development, Certara Evidence & Access Ulrich Neumann, Sr. Director, Head US Access, Certara (ulrich.neumann@certara.com) --- Send in a voice message: https://podcasters.spotify.com/pod/show/market-access/message
  continue reading

4 episoder

Artwork
iconDel
 
Manage episode 214495668 series 2415349
Indhold leveret af Certara Evidence & Access and Certara Evidence. Alt podcastindhold inklusive episoder, grafik og podcastbeskrivelser uploades og leveres direkte af Certara Evidence & Access and Certara Evidence eller deres podcastplatformspartner. Hvis du mener, at nogen bruger dit ophavsretligt beskyttede værk uden din tilladelse, kan du følge processen beskrevet her https://da.player.fm/legal.
In our first episode, we're shining a light on the next frontier for outcomes-based agreements (OBA). If we move beyond the initial excitement and PR, where does pharma stand on risk-sharing and innovative contracting? Experts Roman Casciano, GM, Analytica Laser & SVP, Market Access, HEOR and Real-world Evidence, Certara Lee Stern, VP, Business Development, Certara Evidence & Access Ulrich Neumann, Sr. Director, Head US Access, Certara (ulrich.neumann@certara.com) --- Send in a voice message: https://podcasters.spotify.com/pod/show/market-access/message
  continue reading

4 episoder

すべてのエピソード

×
 
Loading …

Velkommen til Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Hurtig referencevejledning